MDxHealth SA
MDXH
$2.19
-$0.018-0.82%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 36.18% | -8.49% | 27.31% | 13.81% | -41.58% |
| Total Depreciation and Amortization | 16.22% | 1.24% | 16.14% | -52.84% | 107.88% |
| Total Amortization of Deferred Charges | 119.53% | -- | -- | 158.04% | -- |
| Total Other Non-Cash Items | -31.40% | 67.89% | -47.69% | 47.31% | 620.91% |
| Change in Net Operating Assets | 42.06% | 63.54% | -153.15% | -17.44% | 207.23% |
| Cash from Operations | 57.72% | 23.51% | -29.22% | 24.16% | 50.65% |
| Capital Expenditure | 44.83% | 58.57% | 72.05% | 73.87% | -38.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 257.93% | -0.96% | 11.75% | 58.16% | -28.86% |
| Cash from Investing | 66.12% | 50.70% | 50.08% | 68.05% | -34.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 92.67% | -7,444.66% | -25.49% | -192.68% | 13.50% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -122.57% | -111.50% | -34.42% | -46.13% | -262.88% |
| Cash from Financing | 138.55% | 934.17% | -104.58% | -1,481.38% | 4,800.49% |
| Foreign Exchange rate Adjustments | -222.22% | 95.72% | 80.00% | -92.44% | 95.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.06% | 178.00% | -124.08% | 12.90% | 411.91% |